Synergy CHC Corp. (SNYR)

In the past six months, Synergy CHC Corp. reported its third-quarter 2025 financial results with increased revenue and gross margin but decreased net income. The company completed a public offering. The stock experienced a significant decline, attributed to post-IPO dilution, slowing retail sales, and profit margin pressure. There were distribution expansions for its FOCUSfactor brand across Canada and new DSD partnerships in Maine and Pennsylvania, along with retail authorizations in the U.S., Canada, and international markets.

Explicit statements about demand seasonality for Synergy CHC Corp.'s products are not readily available. Quarterly revenue figures show fluctuations, influenced by factors like rebranding, de-inventorying, and new product sell-ins. The company has noted accelerating consumer demand for brain health, focus, and functional energy products, which is driving the expansion of its FOCUSfactor beverage line.

Synergy CHC Corp. markets and distributes consumer branded health and wellness products. Its major product offerings include FOCUSfactor, a brain health supplement; Flat Tummy, a wellness brand for women's nutrition; Hand MD, offering hand care products; Perfekt Beauty, providing beauty products; Sneaky Vaunt, selling shapewear; The Queen Pegasus, for eyelash enhancement; Neuragen, a topical treatment for neuropathic pain; and UrgentRx, offering over-the-counter medications.

Synergy CHC Corp. distributes its products in the United States, Canada, Mexico, and the United Kingdom. The company sells its products through various distribution channels, including club, mass drug, and other retailers such as Costco, Walmart, Amazon, BJ's, Walgreens, CVS, The Vitamin Shoppe, Target.com, H-E-B, Kroger, Wakefern Food Corp., Uniprix, Fortinos, Pilot Flying J, and PriceSmart. It also utilizes television advertising campaigns and online sales for skincare products.

Synergy CHC Corp.'s FOCUSfactor brand has a strong professional reputation, being named the #1 Pharmacist Recommended OTC Memory Supplement for 2025-2026. The company emphasizes that its brands are "heroes" and their reputation is a key measure of success. The Flat Tummy brand has historically leveraged strong branding and social media marketing.

Institutional investors hold approximately 19.52% of Synergy CHC Corp.'s stock, while insiders own about 42.62%. Major institutional shareholders include Gratia Capital, LLC, Heartland Advisors Inc, Vanguard Group Inc, and Knight Therapeutics Inc. CEO and Chairman Jack Ross has made several insider buy transactions.